Porphyrin-related photosensitizers for cancer imaging and therapeutic applications

Journal of Microscopy

Volumn 218, Issue 2, 2005, Pages 133-147

  Berg, K ^a   Selbo, P K ^a   Weyergang, A ^a   Dietze, A ^a   Prasmickaite, L ^a   Bonsted, A ^a   Engesaeter, B O ^a   Angell Petersen, E ^a   Warloe, T ^a   Frandsen, N ^b   Hogset A ^c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Santaris Pharma AS   (Denmark)

^c PCI Biotech AS   (Norway)

Author keywords

Cancer diagnosis; Fluorescence; Gelonin; Gene therapy; Immunotoxin; Paptide nucleic acid; Photodynamic; Photosensitizer

Indexed keywords

BIOACTIVITY; CANCER CELLS; CELL MEMBRANES; CHEMICAL ACTIVATION; DISEASES; GENE ENCODING; GENE THERAPY; HISTOLOGY; MEDICAL IMAGING; NUCLEIC ACIDS; OXYGEN; PEPTIDES; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS; PORPHYRINS; TISSUE;

CANCER DIAGNOSIS; CHEMICAL ENTITY; FLUORESCENCE DIAGNOSIS; GELONIN; IMMUNOTOXINS; PAPTIDE NUCLEIC ACID; PAPTIDES; PHOTOCHEMICAL INTERNALIZATION; PHOTODYNAMIC; PHOTOSENSITISER;

FLUORESCENCE;

ACRIDINE; ALUMINUM; AMINO ACID; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID METHYL ESTER; ANTINEOPLASTIC AGENT; BACTERIOCHLORIN; BENZOPORPHYRIN DERIVATIVE; BLEOMYCIN; CHEMICAL COMPOUND; CHLORIN; CHLORINE DERIVATIVE; CHOLESTEROL; COENZYME A; CYSTEINE; EOSIN; EPIDERMAL GROWTH FACTOR; ESTER DERIVATIVE; GELONIN; GLYCINE; HEMATOPORPHYRIN; HEME; HEMOGLOBIN; HISTIDINE; HORSERADISH PEROXIDASE; IMMUNOTOXIN; INTEGRIN; LUCIFERASE; MACROCYCLIC COMPOUND; MAGNESIUM; MELANIN; METHIONINE; METHYLENE BLUE; NAPHTHALOCYANINE; PEPTIDE NUCLEIC ACID; PHENYLALANINE; PHOTOFRIN; PHOTOSENSE; PHOTOSENSITIZING AGENT; PHTHALOCYANINE; PHTHALOCYANINE ALUMINUM; PHTHALOCYANINE DERIVATIVE; POLYETHYLENEIMINE; POLYLYSINE; PORPHIN; PORPHYRIN DERIVATIVE; PORPHYRINOGEN; PRODRUG; PROTOPORPHYRIN; PSORALEN; PURLYTIN; REACTIVE OXYGEN METABOLITE; RIBOSOME INACTIVATING PROTEIN; SAPORIN; SINGLET OXYGEN; SUCCINYL COENZYME A; TEMOPORFIN; TETRAKIS(4 SULFOPHENYL)PORPHINE; TETRAPHENYLPORPHINESULFONIC ACID; TETRAPYRROLE DERIVATIVE; THYMIDINE KINASE; TRANSFERRIN; TRYPTOPHAN; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ACTINIC KERATOSIS; ADENOVIRUS; BARRETT ESOPHAGUS; BIOSYNTHESIS; BLADDER CANCER; CANCER DIAGNOSIS; CELL MEMBRANE TRANSPORT; CELLULAR DISTRIBUTION; DIAGNOSTIC ACCURACY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG PENETRATION; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; ENDOSOME; FLUORESCENCE; HEAD AND NECK CANCER; HUMAN; IMAGING SYSTEM; INTERNALIZATION; LIGHT ABSORPTION; LIGHT EXPOSURE; MACROMOLECULE; MEMBRANE DAMAGE; NONHUMAN; OUTCOMES RESEARCH; PHARMACOKINETICS; PHOTOCHEMICAL INTERNALIZATION; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PHOTOSENSITIZATION; PLASMID; PRIORITY JOURNAL; PROSTATE CANCER; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; TECHNIQUE; TREATMENT INDICATION; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA;

ADENOVIRIDAE;

EID: 20844456961     PISSN: 00222720     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2818.2005.01471.x     Document Type: Review

References (84)

1. Allen, C.M., Sharman, W.M., La Madeleine, C., Weber, J.M., Langlois, R., Ouellet, R. & van Lier, J.E. (1999) Photodynamic therapy: tumor targeting with adenoviral proteins. Photochem. Photobiol. 70, 512-523.
2. Berg, K. (2001) Basic principles of 5-aminolevulinic-acid based photodynamic therapy. Photodynamic Therapy and Fluorescence Diagnosis in Dermatology (ed. by P. Calzavara-Pinton, B. Ortel and R. M. Szeimies), pp. 115-162. Elsevier, Amsterdam.
3. Berg, K., Madslien, K., Bommer, J.C., Oftebro, R., Winkelman, J.W. & Moan, J. (1991) Light induced relocalization of sulfonated meso- tetraphenylporphines in NHIK 3023 cells and effects of dose fractionation. Photochem. Photobiol. 53, 203-210.
4. Berg, K. & Moan, J. (1994) Lysosomes as photochemical targets. Int. J. Cancer, 59, 814-822.
5. Berg, K., Selbo, P.K., Prasmickaite, L., Tjelle, T.E., Sandvig, K., Moan, J., Gaudernack, G., Fodstad, O., Kjolsrud, S., Anholt, H., Rodal, G.H., Rodal, S.K. & Hogset, A. (1999) Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. Cancer Res. 59. 1180-1183.
6. Berg, K., Western, A., Bommer, J.C. & Moan, J. (1990) Intracellular localization of sulfonated meso-tetraphenylporphines in a human carcinoma cell line. Photochem. Photobiol. 52, 481-487.
7. van den Bergh, H. (2001) Photodynamic therapy of age-related macular degeneration: history and principles. Semin. Ophthalmol. 16, 181-200.
8. Bogaards, A., Varma, A., Collens, S.P., Lin, A., Giles, A., Yang, V.X., Bilbao, J.M., Lilge, L.D., Muller, P.J. & Wilson, B.C. (2004) Increased brain tumor resection using fluorescence image guidance in a preclinical model. Lasers Surg. Med. 35, 181-190.
9. Bonsted, A., Engesaeter, B.O., Hogset, A., Maelandsmo, G.M., Prasmickaite, L., Kaalhus, O. & Berg, K. (2004) Transgene expression is increased by photochemically mediated transduction of polycation-complexed adenoviruses. Gene Ther. 11, 152-160.
10. Bonsted, A., Hogset, A., Hoover, F. & Berg, K. (2005) Photochemical enhancement of glue delivery to glioblastoma cells is dependent on the vector applied. Anticancer Res, in press.
11. Bourre, L., Thibaut, S., Fimiani, M., Ferrand, Y., Simonneaux, G. & Patrice, T. (2003) In vivo photosensitizing efficiency of a diphenylchlorin sensitizer: interest of a DMPC liposome formulation. Pharmacol. Res. 47, 253-261.
12. Brancaleon, L. & Moseley, H. (2002) Laser and non-laser light sources for photodynamic therapy. Lasers Med. Sci. 17, 173-186.
13. Brown, S.B., Brown, E.A. & Walker, I. (2004) The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 5,497-508.
14. Brustad, T., Voss, T., Selbo, P.K., Gärtner, K., Holmøy, T., Nesland, J.M. & Berg, K. (1997) Vital Microscopy and its use to elucidate photodynamic effects. Internet Photochem. Photobiol. 3. http://www.photobiology. com/ vl/selbo/vitalmic.htm.,
15. Canti, G., Lattuada, D., Nicolin, A., Taroni, P., Valentini, G. & Cubeddu, R. (1994) Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light, Anticancer Drugs. 5, 443-447.
16. Chen, J., Stefflova, K., Niedre, M.J., Wilson, B.C., Chance, B., Glickson, J.D. & Zheng, G. (2004) Protease-triggered photosensitizing beacon based on singlet oxygen quenching and activation. J. Am. Chem. Soc. 126, 11450-11451.
17. Cho, Y.W., Kim, J.D. & Park, K. (2003) Polycation gene delivery systems: escape from endosomes to cytosol. J. Pharm. Pharmacol. 55. 721-734.
18. Claydon, P.E. & Ackroyd, R. (2004) 5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus. Dis. Esophagus. 17, 205-212.
19. Cream, C.W., Kavanagh, Y.T., O'Keeffe, C.M., Lawler, M.P., Stevenson, C., Davies, R. J., Boyle, P.H. & Kelly, J.M. (2002) Targeting of photooxidative damage on single-stranded DNA representing the bcr-abl chimeric gene using oligonucleotide-conjugates containing [Ru(phen)3](2+)-like photosensitiser groups. Photochem. Photobiol. Sci. 1, 1024-1033.
20. Curiel, D.T. (1999) Strategies to adapt adenoviral vectors for targeted delivery. Ann. NY Acad. Sci. 886, 158-171.
21. Demidova, T.N. & Hamblin, M.R. (2004) Photodynamic therapy targeted to pathogens. Int. J. Immunopathol. Pharmacol. 17, 245-254.
22. Derendorf, H. & Hochhaus, G. (1995) Handbook of Pharmacokinetics/ Pharmacodynamic Correlation. CRC Press.
23. Dietze, A., Bonsted, A., Hogset, A. & Berg, K. (2003) Photochemical internalization enhances the cytotoxic effect of the protein toxin gelonin and transgene expression in sarcoma cells. Photochem. Photobiol. 78, 283-289.
24. Dobrikov, M.I., Gaidamakov, S.A., Gainutdinov, T.I., Koshkin, A.A. & Vlassov, V.V. (1997) Sensitized photomodification of single-stranded DNA by abinary system of oligonucleotide conjugates. Antisense Nucleic Acid Drug Dev. 7. 309-317.
25. Dolmans, D.E., Fukumura, D. & Jain, R.K. (2003) Photodynamic therapy for cancer. Nat. Rev. Cancer, 3, 380-387.
26. van Dongen, G.A., Visser, G.W. & Vrouenraets, M.B. (2004) Photosensitizer-antibody conjugates for detection and therapy of cancer. Adv. Drug Deliv. Rev. 56, 31-52.
27. Dougherty, T.J., Grindey, G.B., Fiel, R., Weishaupt, K.R. & Boyle, D.G. (1975) Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. J. Natl Cancer Inst. 55, 115-121.
28. Duska, L.R., Hamblin, M.R., Miller, J.L. & Kasan, T. (1999) Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo. J. Natl Cancer Inst. 91, 1557-1563.
29. Endlicher, E., Rummele, P., Hausmann, F., Krieg, R., Knuchel, R., Rath, H.C., Scholmerich, J. & Messmann, H. (2001) Protoporphyrin IX distribution following local application of 5-aminolevulinic acid and its esterified derivatives in the tissue layers of the normal rat colon. Br. J. Cancer, 85, 1572-1576.
30. Engesaeter, B.Ø., Bonsted, A., Berg, K., et al. (2005) PCI enhanced adenoviral transduction employs the known uptake mechanism of adenoviral particles. Cancer Gene Therapy, in press.
31. Ericson, M.B., Sandberg, C., Gudmundson, F., Rosen, A., Larka, Ø. & Wennberg, A.M. (2003) Fluorescence contrast and threshold limit: implications for photodynamic diagnosis of basal cell carcinoma. J. Photochem. Photobiol. B, 69, 121-127.
32. Everts, M. & Curiel, D.T. (2004) Transductional targeting of adenoviral cancer gene therapy. Curr. Gene Ther. 4, 337-346.
33. Fitzpatrick, T.B. & Pathak, M.A. (1959) Historic aspects of methoxsalen and other furocoumarins. J. Invest. Dermatol. 23, 229-231.
34. Folini, M., Berg, K., Millo, E., Villa, R., Prasmickaite, L., Daidone, M.G., Benatti, U. & Zaffaroni, N. (2003) Photochemical internalization of a peptide nucleic acid targeting the catalytic subunit of human telomerase. Cancer Res. 63, 3490-3494.
35. Fritsch, C., Homey, B., Stahl, W., Lehmann, P., Ruzicka, T. & Sies, H. (1998) Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. Photochem. Photobiol. 68, 218-221.
36. Gollnick, S.O., Vaughan, L. & Henderson, B.W. (2002) Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res. 62, 1604-1608.
37. Helium, M., Hogset, A., Engesaeter, B.O., Prasmickaite, L., Stokke, T., Wheeler, C. & Berg, K. (2003) Photochemically enhanced gene delivery with cationic lipid formulations. Photochem. Photobiol. Sci. 2, 407-411.
38. Henderson, B.W. & Bellnier, D.A. (1989) Tissue localization of phetosensitizers and the mechanism of photodynamic tissue destruction. Ciba Found. Symp. 146, 112-125; discussion 125-130.
39. Hogset, A., Ovstebo, E.B., Prasmickaite, L., Berg, K., Fodstad, O. & Maelandsmo, G.M. (2002) Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy. Cancer Gene Ther. 9, 365-371.
40. Hogset, A., Prasmickaite, L., Selbo, P.K., Hellum, M., Engesaeler, B.O., Bonsted, A. & Berg, K. (2004) Photochemical internalisation in drug and gene delivery. Adv. Drug Deliv. Rev. 56, 95-115.
41. Hogset, A., Prasmickaite, L., Tjelle, T.E. & Berg, K. (2000) Photochemical transfection: a new technology for light-induced, site-directed gene delivery. Hum. Gene Ther. 11, 869-880.
42. Huang, Z., Chen, Q., Trncic, N., LaRue, S.M., Brun, P.H., Wilson, B.C., Shapiro, H. & Hetzel, F.W. (2004) Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation. Radiat. Res. 161, 723-731.
43. Joudi, F.N. & Konety, B.R. (2004) Fluorescence cystoscopy and bladder surveillance. Curr. Opin. Urol. 14, 265-270.
44. Kessel, D. (1986) Porphyrin-lipoprotein association as a factor in porphyrin localization. Cancer Lett. 33, 183-188.
45. Kloeckner, J., Prasmickaite, L., Hogset, A., Berg, K. & Wagner, E. (2004) Photochemically enhanced gene delivery of EGF receptor-targeted DNA polyplexes. J. Drug Target, 12, 205-213.
46. Kormeili, T., Yamauchi, P.S. & Lowe, N.J. (2004) Topical photodynamic therapy in clinical dermatology. Br. J. Dermatol. 150, 1061-1069.
47. Lopez, R.F., Lange, N., Guy, R. & Bentley, M.V. (2004) Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. Adv. Drug Deliv. Rev. 56, 77-94.
48. MacDonald, I.J. & Dougherty, T.J. (2001) Basic principles of photodynamic therapy. J. Porphyrins Phthalocyanines, 5, 105-129.
49. Maisch, T., Szeimies, R.M., Jori, G. & Abels, C. (2004) Antibacterial photodynamic therapy in dermatology. Photochem. Photobiol. Sci. 3, 907-917.
50. Maurice-Duelli, A., Ndoye, A., Bouali, S., Leroux, A. & Merlin, J.L. (2004) Enhanced cell growth inhibition following PTEN nonviral gene transfer using polyethylenimine and photochemical internalization in endometrial cancer cells. Technol Cancer Res. Treat. 3, 459-465.
51. Mayinger, B., Neidhardt, S., Reh, H., Martus, P. & Hahn, E.G. (2001) Fluorescence induced with 5-aminolevulinic acid for the endoscopic detection and follow-up of esophageal lesions. Gastrointest. Endosc. 54, 572-578.
52. Moan, J. & Berg, K. (1991) The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem. Photobiol. 53, 549-553.
53. Moan, J. & Peng, Q. (2003) An outline of the hundred-year history of PDT. Anticancer Res. 23, 3591-3600.
54. Moan, J., Pettersen, E.O. & Christensen, T. (1979) The mechanism of photodynamic inactivation of human cells in vitro in the presence of haematoporphyrin. Br. J. Cancer, 39, 398-407.
55. Ndoye, A., Bouali, S., Dolivet, G., Leroux, A., Erbacher, P., Behr, J.P., Berg, K., Guillemin, F. & Merlin, J.L. (2004a) Sustained gene transfer and enhanced cell death following glucosylated-PEI-mediated p53 gene transfer with photochemical internalisation in p53-mutated head and neck carcinoma cells. Int. J. Oncol 25, 1575-1581.
56. Ndoye, A., Merlin, J.L., Leroux, A., Dolivet, G., Erbacher, P., Behr, J.P., Berg, K. & Guillemin, F. (2004b) Enhanced gene transfer and cell death following p53 gene transfer using photochemical internalisation of glucosylated PEI-DNA complexes. J. Gene Med. 6, 884-894.
57. Niedre, M., Patterson, M.S. & Wilson, B.C. (2002) Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo. Photochem. Photobiol. 75, 382-391.
58. Niedre, M.J., Secord, A.J., Patterson, M.S. & Wilson, B.C. (2003) In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy. Cancer Res. 63, 7986-7994.
59. Peng, Q., Berg, K., Moan, J., Kongshaug, M. & Nesland, J.M. (1997a) 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem. Photobiol. 65, 235-251.
60. Peng, Q., Moan, J. & Cheng, L.S. (1991) The effect of glucose administration on the uptake of photofrin II in a human tumor xenograft. Cancer Lett. 58, 29-35.
61. Peng, Q., Soler, A.M., Warloe, T., Nesland, J.M. & Giercksky, K.E. (2001) Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J. Photochem. Photobiol. B, 62, 140-145.
62. Peng, Q., Warloe, T., Berg, K., Moan, J., Kongshaug, M., Giercksky, K.E. & Nesland, J.M. (1997b) 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer, 79, 2282-2308.
63. Prasmickaite, L., Hogset, A. & Berg, K. (2001) Evaluation of different photosensitizers for use in photochemical gene transfection. Photochem. Photobiol. 73, 388-395.
64. Prasmickaite, L., Hogset, A., Olsen, V.M., Kaalhus, O., Mikalsen, S.O. & Berg, K. (2004) Photochemically enhanced gene transfection increases the cytotoxicity of the herpes simplex virus thymidine kinase gene combined with ganciclovir. Cancer Gene Ther. 11, 514-523.
65. Prasmickaite, L., Hogset, A., Tjelle, T.E., Olsen, V.M. & Berg, K. (2000) Role of endosomes in gene transfection mediated by photochemical internalisation (PCI). J. Gene Med. 2, 477-488.
66. Raab, O. (1900) Ueber die Wirkung fluorescierenden Stoffe auf infusorien nach versuchen von O.Raab. Z. Biol. 39, 524-546.
67. Schmidbauer, J., Witjes, F., Schmeller, N., Donat, R., Susani, M. & Marberger, M. (2004) Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J. Urol. 171, 135-138.
68. Schmidt, M., Maurer-Gebhard, M., Groner, B., Kohler, G., Brochmann-Santos, G. & Wels, W. (1999) Suppression of metastasis formation by a recombinant single chain antibody-toxin targeted to full-length and oncogenic variant EGF receptors. Oncogene, 18, 1711-1721.
69. Selbo, P.K., Kaalhus, O., Sivam, G. & Berg, K. (2001a) 5-Aminolevulinic acid-based photochemical internalization of the immunotoxin MOC31-gelonin generates synergistic cytotoxic effects in vitro. Photochem. Photobiol. 74, 303-310.
70. Selbo, P.K., Sandvig, K., Kirveliene, V. & Berg, K. (2000a) Release of gelonin from endosomes and lysosomes to cytosol by photochemical internalization. Biochim. Biophys. Acta. 1475, 307-313.
71. Selbo, P.K., Sivam, G., Fodstad, O., Sandvig, K. & Berg, K. (2000b) Photochemical internalisation increases the cytotoxic effect of the immunotoxin MOC31-gelonin. Int. J. Cancer, 87, 853-859.
72. Selbo, P.K., Sivam, G., Fodstad, O., Sandvig, K. & Berg, K. (2001b) In vivo documentation of photochemical internalization. a novel approach to site specific cancer therapy. Int. J. Cancer, 92, 761-766.
73. Selkirk, S.M. (2004) Gene therapy in clinical medicine. Postgrad. Med. J. 80, 560-570.
74. Sharman, W.M., Allen, C.M. & van Lier, J.E. (1999) Photodynamic therapeutics: basic principles and clinical applications. Drug Discov. Today, 4, 507-517.
75. Shiah, J.G., Sun, Y., Peterson, C.M., Straight, R.C. & Kopecek, J. (2000) Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments. Clin. Cancer Res. 6, 1008-1015.
76. Sonoda, M., Krishna, C.M. & Riesz, P. (1987) The role of singlet oxygen in the photohemolysis of red blood cells sensitized by phthalocyanine sulfonates. Photochem. Photobiol. 46, 625-631.
77. Stefanidou, M., Tosca, A., Themelis, G., Vazgiouraki, E. & Balas, C. (2000) In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy. Eur. J. Dermatol. 10, 351-356.
78. Stummer, W., Reulen, H.J., Novotny, A., Stepp, H. & Tonn, J.C. (2003) Fluorescence-guided resections of malignant gliomas - an overview. Acta Neurochir. Suppl. 88, 9-12.
79. Sullenger, B.A. & Gilboa, E. (2002) Emerging clinical applications of RNA. Nature, 418, 252-258.
80. von Tappeiner, H., & Jesionek A. (1903) Terapeutiche Versuche mit fluorescierenden Stoffen. Munch. Med. Worchenschr. 47, 2042-2044.
81. Weersink, R.A., Forbes, J., Bisland, S., Trachtenberg, J., Elhilali, M., Brun, P.H. & Wilson, B.C. (2005) Assessment of cutaneous photosensitivity of TOOKAD (WST09) in pre-clinical animal models and in patients. Photochem. Photobiol. 81, 106-113.
82. Wels, W., Biburger, M., Muller, T., Dalken, B., Giesubel, U., Tonn, T. & Uherek, C. (2004) Recombinant immunotoxins and retargeted killer cells: employing engineered antibody fragments for tumor-specific targeting of cytotoxic effectors. Cancer Immunol. Immunother. 53, 217-226.
83. Yang, V.X., Muller, P.J., Herman, P. & Wilson, B.C. (2003) A multispectral fluorescence imaging system: design and initial clinical tests in intraoperative Photofrin-photodynamic therapy of brain tumors. Lasers Surg. Med. 32, 224-232.
84. Zimmermann, A., Ritsch-Marte, M. & Kostron, H. (2001) mTKPC-mediated photodynamic diagnosis of malignant brain tumors. Photochem. Photobiol. 74, 611-616.